American Well Corporation

NYSE:AMWL

Medical - Healthcare Information Services

Healthcare
$11.03 +2.82%

+$0.24 today

Market cap
$171.77M
Beta
1.70
P/E (TTM)
-1.6
EPS (TTM)
-$5.30
52W Low $3.71High $9.96

Volume 0.06M

Average 0.07M

AMWL Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

American Well CorporationNYSE: AMWL

Gross Margin · Q1 FY2026 · quarter ended Mar 2026

Gross margin narrows to 37.2%

Gross margin was 37.2% in Q1 FY2026, down 15.6 pp from a year earlier. On a trailing-twelve-month basis it was 49.7%, up 5.4 pp year over year. Over 3 fiscal years it widened by 11.2 pp.

Context

  • Gross margin widened in 2 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
37.2%-14.1 pp QoQ
Last fiscal yearDec 2025
53.3%+14.4 pp YoY
LTMMar 2026
49.7%+5.4 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-15.6 pp——
1 year+14.4 pp——
3 years+11.2 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
53.3%
Year-over-year change
+14.4pp

Gross Margin vs competitors

How AMWL compares with its peers on the latest reported figures

  • AMWL's LTM Mar 2026 gross margin of 49.7% is the 3rd highest of the 5 companies compared; the peer median is 60.1%.
  • Its year-over-year change of +5.4 pp is the 3rd highest of 4, against a peer median of +21.6 pp.
  • Over three fiscal years its change of +11.2 pp compares with a peer median of -8.0 pp.
AMWL Competitors Peer median
Gross Margin for AMWL and competitors
Company Period LTM level YoY 3-year change
DTILPrecision BioSciences, Inc.LTM Mar 202697.0% -3.0 pp-8.0 pp
CAMPCAMP4 Therapeutics CorporationLTM Mar 202676.2% +30.8 pp—
AMWLAmerican Well CorporationLTM Mar 202649.7% +5.4 pp+11.2 pp
EUDAEUDA Health Holdings LimitedLTM Jun 202644.0% +21.6 pp+20.8 pp
ATYRaTyr Pharma, Inc.LTM Mar 2026-11754.7% —-801.0 pp
ALXOALX Oncology Holdings Inc.FY2025— ——
IMUXImmunic, Inc.FY2025— ——
BMEABiomea Fusion, Inc.FY2025— ——
GUTSFractyl Health, Inc. Common StockFY2025— ——
Peer median (excluding AMWL) 60.1%+21.6 pp-8.0 pp

Competitors are the stored peer set for AMWL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue252.79M277.19M259.05M254.36M249.33M
Cost of Revenue148.47M160.42M164.29M155.41M116.47M
Gross Profit104.32M116.77M94.76M98.95M132.86M
Gross Margin41.3%42.1%36.6%38.9%53.3%
Research & Development106.59M138.49M105.83M86.07M72.86M
Selling, General & Admin160.78M227.98M213.11M197.45M131.31M
Operating Expenses283.46M392.62M786.9M316.49M238.13M
Depreciation & Amortization16.09M26.17M31.51M32.98M33.96M
EBITDA(166.07M)(245.84M)(224.15M)(176.91M)(60.57M)
EBITDA Margin-65.7%-88.7%-86.5%-69.6%-24.3%
Operating Income(179.15M)(275.85M)(692.14M)(217.53M)(105.27M)
Operating Margin-70.9%-99.5%-267.2%-85.5%-42.2%
Interest Income120K6.12M19.42M10.76M3.8M
Interest Expense00000
Other Income / Expenses(3.01M)3.85M16.83M7.65M10.74M
Income Before Tax(182.16M)(272.01M)(675.31M)(209.89M)(94.53M)
Pre-Tax Margin-72.1%-98.1%-260.7%-82.5%-37.9%
Income Tax Expense(5.38M)64K3.86M2.75M434K
Net Income(176.33M)(270.43M)(675.16M)(208.14M)(95.7M)
Net Margin-69.8%-97.6%-260.6%-81.8%-38.4%
EPS (Basic)(13.88)(19.68)(47.50)(13.88)(5.96)
EPS (Diluted)(13.88)(19.68)(47.50)(13.88)(5.96)
Weighted Avg Shares12.7M13.71M14.21M15M16.05M
Weighted Avg Shares (Diluted)12.7M13.71M14.21M15M16.05M

American Well Corporation

NYSE:AMWL

Intrinsic Alpha fair value

Locked

Current Price

$11.03

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.